Tru Independence Asset Management 2’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$3.3M Buy
+5,729
New +$3.23M 3.32% 5
2022
Q3
$804K Buy
1,584
+458
+41% +$256K 0.85% 20
2022
Q2
$612K Sell
1,126
-581
-34% -$320K 0.5% 30
2022
Q1
$1.01M Sell
1,707
-583
-25% -$335K 0.58% 31
2021
Q4
$1.53M Buy
2,290
+53
+2% +$33.1K 0.81% 26
2021
Q3
$1.28M Buy
2,237
+89
+4% +$48.8K 0.91% 21
2021
Q2
$1.08M Sell
2,148
-40
-2% -$18.9K 0.74% 32
2021
Q1
$999K Buy
2,188
+65
+3% +$31K 0.79% 31
2020
Q4
$989K Buy
+2,123
New +$995K 0.83% 28

Other funds holding TMO

Tru Independence Asset Management 2's TMO Position: Q1 2023 in Review

Tru Independence Asset Management 2 opened a new position in Thermo Fisher Scientific (TMO) in Q1 2023: 5,729 shares worth $3.3M. The stake represents 3.32% of the portfolio and ranks #5 among its holdings. This is a return to the name: Tru Independence Asset Management 2 previously reported a position in TMO as recently as Q3 2022.

Tru Independence Asset Management 2 first reported a position in TMO in Q4 2020 and has held it in 9 quarters since. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Tru Independence Asset Management 2 held 5,729 shares of Thermo Fisher Scientific worth $3.3M as of Q1 2023.
  • Thermo Fisher Scientific was a new Tru Independence Asset Management 2 position in Q1 2023.
  • Thermo Fisher Scientific made up 3.32% of Tru Independence Asset Management 2's portfolio in Q1 2023, its #5 holding.
  • Tru Independence Asset Management 2 first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 9 quarters since.
  • 2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Tru Independence Asset Management 2's 13F filing for Q1 2023, filed 26 Apr 2023.